Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2013
05/02/2013WO2013062425A1 Ionophore antibiotic veterinary composition and method of manufacture
05/02/2013WO2013062424A1 Method and composition for the treatment of pain and/or inflammation
05/02/2013WO2013062402A1 Allergy treatment with non- digestible oligosaccharide
05/02/2013WO2013062344A1 Hydroxamate derivatives for hdac inhibitor, and the pharmaceutical composition comprising thereof
05/02/2013WO2013062333A1 Composition comprising syringaresinol for improving the skin
05/02/2013WO2013062332A2 Vascular anti-aging composition including syringaresinol
05/02/2013WO2013062316A2 Composition containing modafinil or the derivatives thereof for treating vascular diseases or kca3.1-channel-mediated diseases
05/02/2013WO2013062294A2 Improved preparation method for mitiglinide calcium
05/02/2013WO2013062247A2 Phorbol type diterpene compound, pharmaceutical composition for treatment or prevention of viral infectious diseases including same
05/02/2013WO2013062190A1 Cooling composition
05/02/2013WO2013062181A1 Capsosiphon fulvescens glycoprotein extract having liver protection effect and composition containing same
05/02/2013WO2013062079A1 Dihydroimidazooxazole derivative
05/02/2013WO2013062074A1 Imidazolone derivative
05/02/2013WO2013062073A1 Orally disintegrating tablet containing low-dose ramosetron
05/02/2013WO2013062071A1 Piperazine derivative and salt thereof
05/02/2013WO2013062065A1 Aminoalkyl-substituted n-thienyl benzamide derivative
05/02/2013WO2013062050A1 Aqueous gemcitabine solution preparation
05/02/2013WO2013062028A1 Hiv replication inhibitor
05/02/2013WO2013062027A1 Azole derivative
05/02/2013WO2013061977A1 Heterocycle derivative having pgd2 receptor antagonist activity
05/02/2013WO2013061969A1 Oxybutynin-containing transdermal absorption preparation
05/02/2013WO2013061962A1 Bicyclic compound
05/02/2013WO2013061919A1 Novel compound and method for producing same
05/02/2013WO2013061816A1 Novel compound contained in manuka honey and use of same
05/02/2013WO2013061724A1 Radical inhibitor
05/02/2013WO2013061669A1 Benzohydrazide derivative for inducing g2/m phase arrest and cell death
05/02/2013WO2013061588A1 Transdermally absorbed preparation
05/02/2013WO2013061455A1 Novel resveratrol polymerization compound or pharmaceutically acceptable salt thereof
05/02/2013WO2013061350A1 Improved cross-linking composition delivered by iontophoresis, useful for the treatment of keratoconus
05/02/2013WO2013061329A1 Lipid conjugates in the treatment of chronic rhinosinusitis
05/02/2013WO2013061328A2 Method of treating cancer
05/02/2013WO2013061297A1 Pyridazine Derivatives Useful in Therapy
05/02/2013WO2013061295A1 Inhibition of viral gene expression
05/02/2013WO2013061279A1 Uses of indole-ketones or indolidones as neuro-protective drugs
05/02/2013WO2013061269A1 Combinations of loteprednol and olopatadine for the treatment of ocular allergies
05/02/2013WO2013061161A2 New combination therapies for treating neurological disorders
05/02/2013WO2013061101A1 Primycin and components thereof for use in the treatment or prevention of infections caused by specific pathogens
05/02/2013WO2013061091A2 Cystic fibrosis treatment
05/02/2013WO2013061080A1 Anticancer pyridopyrazines via the inhibition of fgfr kinases
05/02/2013WO2013061077A1 New compounds
05/02/2013WO2013061074A1 Quinolines as fgfr kinase modulators
05/02/2013WO2013061005A1 Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies
05/02/2013WO2013061004A1 Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
05/02/2013WO2013061002A1 Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
05/02/2013WO2013060964A1 Novel esters of n-acyl derivatives of amino acids and diols, method for preparing same, and use thereof in cosmetics and as a drug
05/02/2013WO2013060936A1 Aqueous antimicrobial composition containing coniferous resin acids
05/02/2013WO2013060908A1 Use of a melatonin analogue for the reduction of intraocular pressure
05/02/2013WO2013060889A1 Compounds for the treatment of influenza
05/02/2013WO2013060881A1 Pyridopyrimidines and their therapeutic use
05/02/2013WO2013060872A1 Anticancer combination therapy
05/02/2013WO2013060860A1 N-acyl-n'-phenylpiperazine derivatives as srbp modulators for use in the treatment of diabetes and obesity
05/02/2013WO2013060850A1 Treatment protocol of diabetes type 2
05/02/2013WO2013060837A1 Synthesis of triazolopyrimidine compounds
05/02/2013WO2013060751A1 Novel pyrazine derivatives
05/02/2013WO2013060744A2 Compounds having an ethr inhibiting activity - use of said compounds as drugs - pharmaceutical composition and product containing said compounds
05/02/2013WO2013060673A1 Quinone based nitric oxide donating compounds
05/02/2013WO2013060668A1 New therapy for transthyretin-associated amyloidosis
05/02/2013WO2013060653A1 1-cycloalkyl- or 1-heterocyclyl-hydroxyimino-3-phenyl-propanes
05/02/2013WO2013060636A1 6-(4-hydroxy-phenyl)-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
05/02/2013WO2013060343A1 Sublingual pharmaceutical composition containing an antihistamine agent and method for the preparation thereof
05/02/2013WO2013060307A1 Carbonic anhydrase inhibitors and method of their production
05/02/2013WO2013060305A1 Pharmaceutical composition for elimination of cancer stem cells
05/02/2013WO2013060304A1 Solid dispersion of paclitaxel or homologue thereof and preparation method therefor
05/02/2013WO2013060274A1 Derivatives of protoberberine biological alkaloids and use of same inhibiting ulcerative colitis
05/02/2013WO2013060258A1 Clavatine a-c, preparation method thereof and pharmaceutical composition and use thereof
05/02/2013WO2013060179A1 Acyltetrahydro-β-carboline compounds as well as derivatives, applications and preparation methods thereof
05/02/2013WO2013060098A1 Kinase inhibitor and method for treatment of related diseases
05/02/2013WO2013060097A1 Novel compound as kcnq potassium channel agonist, preparation method therefor and use thereof
05/02/2013WO2013060029A1 Allosteric modulators of metabotropic glutamate receptors
05/02/2013WO2013060005A1 Method for detecting specific single nucleotide polymorphism related to ankylosing spondylitis and kit therefor
05/02/2013WO2013060004A1 Method for detecting specific single nucleotide polymorphism related to ankylosing spondylitis and kit therefor
05/02/2013WO2013059984A1 Derivative of methacryloyl-benzimidazol-one (thione) and use thereof as anti-microbial drug
05/02/2013WO2013059944A1 Epigenetic regulators and uses thereof
05/02/2013WO2013059942A1 Use of a ginseng extract to prevent and treat alopecia areata
05/02/2013WO2013059928A1 Hiv protease inhibitors
05/02/2013WO2013059927A1 Compounds targeting the cell invasion protein complex, their pharmaceutical compositions and methods of use thereof
05/02/2013WO2013059898A1 Pharmaceutical compositions containing sesquiterpene lactones belonging to the class of furan heliangolides for the treatment of parasitic infections and tumours
05/02/2013WO2013059896A1 Use of pyranonaphthoquinone as an anti-viral agent; pharmaceutical composition containing pyranonaphthoquinones; medicament containing pyranonaphthoquinones for treating infections by dengue virus
05/02/2013WO2013059881A1 Electrolyte purgatives
05/02/2013WO2013059879A1 Compositions and methods for the treatment of fibrosis and fibrotic diseases
05/02/2013WO2013059876A1 A method of treating mucus hypersecretion
05/02/2013WO2013052006A8 Parp-1 inhibitors
05/02/2013WO2013040295A3 Divalent-metal coated nanoparticles for delivery of compositions into the central nervous system by nasal insufflation
05/02/2013WO2013036912A3 Amido compounds as rorϒtmodulators and uses thereof
05/02/2013WO2013036867A3 Compositions and methods for cancer and cancer stem cell detection and elimination
05/02/2013WO2013036846A3 N4 derivatives of deoxycytidine prodrugs
05/02/2013WO2013036783A3 Methods for treating intrapulmonary infections
05/02/2013WO2013036610A3 Compositions comprising mg53 and methods for the treatment and prevention of airway injury
05/02/2013WO2013036081A3 Composition for reducing skin wrinkles including pde5 inhibitor
05/02/2013WO2013036053A3 Solid dispersion comprising tacrolimus and method for preparing the same
05/02/2013WO2013036015A3 Azetidine derivative and antidepressant composition containing same
05/02/2013WO2013035997A9 Pharmaceutical composition for preventing or treating alopecia comprising tianeptine or its salt
05/02/2013WO2013033626A3 Nkp30 receptor targeted therapeutics
05/02/2013WO2013033246A9 Novel benzodiazepinones as modulators of metabotropic glutamate receptor functions and neurological uses thereof
05/02/2013WO2013030679A3 Sustained release delivery of active agents to treat glaucoma and ocular hypertension
05/02/2013WO2013028832A3 Inhibitors of nedd8-activating enzyme
05/02/2013WO2013025984A3 Cannabinoid receptor treatments
05/02/2013WO2013015661A3 Novel prodrugs of 5-(2,4-dihydroxy-5-isopropylphenyl)-n-ethyl-4-(5-methyl1-1,2,4-oxadiazol-3-yl)isoxazole-3-carboxamide
05/02/2013WO2012174262A9 Formulations and methods of treating subjects having central nervous system, endocrine, inflammatory or cardiovascular disorders or at-risk thereof with highly purified omega-3 fatty acid formulations
05/02/2013WO2012173392A9 Curcuminoid-based compound/stevioside-containing complex for the prevention and treatment of an influenza virus infection
1 ... 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 ... 7860